Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome
This study has been completed.
Study NCT00013689. Last updated on March 3, 2008.
Information provided by National Institutes of Health Clinical Center (CC)
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autoimmune Disease
Lymphoproliferative Disorder
Additional conditions recognized in this trial
Anemia, Hemolytic, Autoimmune
Autoimmune Diseases
Lymphoproliferative Disorders
Syndrome
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Disease
Hematologic Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Pathologic Processes
Additional drug interventions recognized in this trial
Pyrimethamine
Sulfadoxine
Sulfadoxine-pyrimethamine
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antimalarials
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Back to top of Main Content